Clinical Trial Update: PD-1 Antibody in EBV Positive Metastatic Gastric Cancer Patients. [Phase 2]

View source ↗

Summary

Phase 2 trial update of a PD-1 antibody in patients with EBV-positive metastatic gastric cancer (Stage IV).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebv-positive Gastric Cancer
• Gastric Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Gastric Cancer Stage IV, EBV | Phase 2 | Status: COMPLETED